Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05877365 · ClinicalTrials.gov registry record · NA
Effects of 21-day Purification Program on Healthy Adults
A NA study, sponsored by Standard Process.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT05877365: Completed NA study, sponsored by Standard Process.
NCT05877365 is a NA study that has completed, run by Standard Process. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05877365, a NA study, has completed, sponsored by Standard Process.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This is a study to assess the impact of Standard Process's 21-Day Purification Program on metabolic health. Participants will be given the opportunity to consume the complex combination of vitamins, minerals, and antioxidants that comprise the 21-Day Guided Purification Program by Standard Process.
Primary Outcome
Using a kit, urinary porphyrins will be measured.
Interventions
- DIETARY_SUPPLEMENT Standard Process 21-Day Purification Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2023-06-15 |
| Est. Completion | 2024-01-15 |
| Phase | NA |
What the finished NCT05877365 record still lists
NCT05877365 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Standard Process 21-Day Purification Program is the first listed.
NCT05877365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05877365 about?
NCT05877365 is a clinical study titled "Effects of 21-day Purification Program on Healthy Adults". This is a study to assess the impact of Standard Process's 21-Day Purification Program on metabolic health. Participants will be given the opportunity to consume the complex combination of vitamins, minerals, and antioxidants that comprise the 21-Day Guided Purification Program by Standard Process.
What is the current status of trial NCT05877365?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2023-06-15. Estimated completion is 2024-01-15.
What interventions are being tested in trial NCT05877365?
The interventions under investigation include: Standard Process 21-Day Purification Program (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05877365?
This trial is sponsored by Standard Process, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05877365's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI